Article: Astellas Pharma US, announced that the FDA-approved Vaprisol (conivaptan hydrochloride injection), an arginine vasopressin receptor antagonist, for the intravenous treatment of hypervolemic hyponatremia in hospitalized patients.(PRODUCT NEWS)

Article: Study Shows Vasopressin Receptor Antagonist ...
PR Newswire;  September 20, 2007 ;     700+ words ... ... in patients with euvolemic or hypervolemic hyponatremia," said Joseph G. Verbalis ... clinical need for euvolemic or hypervolemic hyponatremia in hospitalized patients ... a treatment for euvolemic and hypervolemic hyponatremia in hospitalized patients. VAPRISOL ...

Article: FDA clears Astellas' Vaprisol for hypervolemic ...
Pharma Marketletter;  March 12, 2007 ;     700+ words ... ... arginine vasopressin receptor antagonist ... treatment of hypervolemic hyponatremia in hospitalized ... euvolemic and hypervolemic hyponatremia, potentially ... and death. Hypervolemic hyponatremia, which occurs ...

Article: FDA Approves Astellas' Vaprisol(R) for the Treatment of ...
PR Newswire;  March 2, 2007 ;     700+ words ... ... treatment of hypervolemic hyponatremia in hospitalized ... patients with hypervolemic hyponatremia. Aquaresis ... V1a and V2 vasopressin receptor antagonist ... euvolemic and hypervolemic hyponatremia, is the ...

Article: Study Shows Vasopressin Receptor Antagonist ...
PR Newswire;  September 15, 2004 ;     700+ words ... ... is being reviewed by the U.S. Food and Drug Administration (FDA) for the treatment of euvolemic and hypervolemic hyponatremia. If approved, it will be the first drug specifically indicated for this condition. Current treatments ...

Article: Data Show Vaprisol(R) Is Effective & Safe in Promptly Increasing ...
PR Newswire;  October 10, 2007 ;     700+ words ... ... hospitalized patients with euvolemic and hypervolemic hyponatremia with a low risk of overly rapid ... in patients with euvolemic and hypervolemic hyponatremia." Vaprisol is the first in ... a treatment for euvolemic and hypervolemic hyponatremia in hospitalized patients. Vaprisol ...

Article: Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium ...
PR Newswire;  October 25, 2007 ;     700+ words ... ... hospitalized patients with euvolemic or hypervolemic hyponatremia, a potentially life-threatening ... a treatment for euvolemic and hypervolemic hyponatremia in hospitalized patients. VAPRISOL ... patients, all with euvolemic or hypervolemic hyponatremia. After infusion of a 20 mg ...

Article: Aminoglycoside rescues disease-causing mutation in ...
Proteomics Weekly;  June 28, 2004 ;     700+ words ... ... causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo. According ... system, we studied a mutant V2 vasopressin receptor (AVPR2) containing the inactivating ... causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo. Hum ...